Home › Clear-cell metastatic renal cell carcinoma › California
Clear-cell metastatic renal cell carcinoma clinical trials in California
9 studies for Clear-cell metastatic renal cell carcinoma are looking for participants at sites in California.
Cities in California
Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma
- NEO-811 Los Angeles Site, Duarte
- NEO-811 San Diego Site, San Diego
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 5, 2026 · NCT07300241Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
- Research Site, Duarte
- Research Site, Irvine
- Research Site, La Jolla
- and 4 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT07011719Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
- City of Hope (City of Hope National Medical Center, City of Hope Medical Center), Duarte
- City of Hope Investigational Drug Services (IDS), Duarte
- UC San Diego Medical Center - Encinitas, Encinitas
- and 13 more
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT07227415Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study
- City of Hope National Medical Center, Duarte
- Chao Family Comprehensive Cancer Center, Orange
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 19, 2026 · NCT05361720Zanzalintinib for Metastatic Clear Cell Renal Cell Carcinoma With Bone Metastases
- University of California, San Francisco, San Francisco
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 27, 2026 · NCT07043608Imaging of Solid Tumors Using 18F-TRX
- University of California, San Francisco, San Francisco
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jul 23, 2026 · NCT06942104Immunotherapy (Nivolumab and Ipilimumab) With and Without a Live Biotherapeutic Product (EXL01) for the Treatment of Metastatic Renal Cell Cancer
- City of Hope Medical Center, Duarte
- City of Hope Medical Center, Irvine
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jul 16, 2026 · NCT07128680Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
- PCR Oncology, Arroyo Grande
- Sutter Auburn Faith Hospital, Auburn
- Sutter Cancer Centers Radiation Oncology Services-Auburn, Auburn
- and 34 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 9, 2025 · NCT04510597CBM588 Capsules in Combination With Nivolumab and Ipilimumab for the Treatment of Advanced Stage Kidney Cancer
- City of Hope Medical Center, Duarte
RecruitingPhase 1
Ages 18 and older · All sexes · Updated May 30, 2024 · NCT06399419From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.